» Articles » PMID: 19948580

Cost of Vaccine Administration Among Pediatric Practices

Overview
Journal Pediatrics
Specialty Pediatrics
Date 2009 Dec 2
PMID 19948580
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The goal was to describe variable costs to providers of delivering childhood immunizations.

Methods: We documented variable costs (costs that vary with the amount of services rendered), including time spent by pediatric staff members and physicians on immunization-related activities, as well as supply costs and medical waste disposal costs. Ten private pediatric practices in the Denver, Colorado, metropolitan area participated in the study. Among the 7 practices that provided us with payment data, 8 health plans were mentioned by > or = 2 practices. There were 37 different agreements between the health plans and practices for vaccine administration payments.

Results: The total documented variable cost per injection (excluding vaccine cost) averaged $11.51, calculated from the following categories: nursing time, $1.71; billing services, $2.67; nonroutine services, $1.64; registry use, $0.96; physician time, $4.05; supplies, $0.36; medical waste disposal, $0.12. Nonroutine activities primarily included performing vaccine inventory and ordering, providing vaccination records to requesters, and answering parent telephone questions about vaccinations. With the use of a simulation model to compensate for the small number of participating practices, the calculated total variable cost per injection was $11.83. When 2 vaccines were administered, we compared the sum of the 2 payments with the sum of the 2 variable costs ($23.02). More than one third of the payment agreements (13 of 37 agreements) paid the practices less than the combined variable costs for 2 immunizations.

Conclusion: This study shows that the variable costs of vaccine administration exceeded reimbursement from some insurers and health plans.

Citing Articles

Public health impact and cost-effectiveness of 15-valent pneumococcal conjugate vaccine use among the pediatric population of the United States.

Prasad N, Stoecker C, Xing W, Cho B, Leidner A, Kobayashi M Vaccine. 2023; 41(18):2914-2921.

PMID: 37012118 PMC: 10962013. DOI: 10.1016/j.vaccine.2023.03.045.


Time and labour costs of preventive health care, including vaccinations, in Finnish child health clinics.

Nieminen H, Hakulinen T, Puumalainen T, Siren P, Palmu A PLoS One. 2022; 17(10):e0270835.

PMID: 36190966 PMC: 9529095. DOI: 10.1371/journal.pone.0270835.


Time and cost of administering COVID-19 mRNA vaccines in the United States.

Yarnoff B, Bodhaine S, Cohen E, Buck P Hum Vaccin Immunother. 2021; 17(11):3871-3875.

PMID: 34613860 PMC: 8828150. DOI: 10.1080/21645515.2021.1974289.


Challenges with hepatitis B vaccination of high risk adults - A pilot program.

Bridges C, Watson T, Nelson N, Chavez-Torres M, Fineis P, Ntiri-Reid B Vaccine. 2019; 37(35):5111-5120.

PMID: 31303523 PMC: 8819536. DOI: 10.1016/j.vaccine.2019.05.089.


Insurance Reimbursements for Routinely Recommended Adult Vaccines in the Private Sector.

Tsai Y, Zhou F, Lindley M Am J Prev Med. 2019; 57(2):180-190.

PMID: 31248743 PMC: 6732785. DOI: 10.1016/j.amepre.2019.03.011.